Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Viridian Therapeutics has announced new inducement grants approved under Nasdaq Listing Rule 5635(c)(4). Released from Waltham, Mass. on October 2, 2025, this update highlights the company’s adherence to key regulatory requirements.
4 days ago
1 min read
